Iveric Bio Inc (NASDAQ:ISEE)

13.66
Delayed Data
As of Jan 14
 +0.68 / +5.24%
Today’s Change
4.96
Today|||52-Week Range
19.32
-18.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.6B

Company Description

IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in New York, NY.

Contact Information

IVERIC bio, Inc.
Five Penn Plaza
New York New York 10001
P:(212) 845-8200
Investor Relations:
(212) 845-8231

Employees

Shareholders

Other institutional57.19%
Mutual fund holders30.05%
Individual stakeholders2.09%

Top Executives

Glenn P. SblendorioChief Executive Officer & Director
Pravin U. DugelPresident
Keith WestbyChief Operating Officer & Senior Vice President
David F. CarrollChief Financial Officer, Treasurer & Senior VP
Xiao Ping DaiChief Technical Officer